Tracleer Label Change Iminent! Inside Scoop!

Discussion in 'Actelion' started by Anonymous, Mar 26, 2011 at 9:53 PM.

Tags: Add Tags
  1. #1 Anonymous, Mar 26, 2011 at 9:53 PM
    Anonymous

    Anonymous Guest

    The new label will say "removed from US market for underreporting deaths"
     
    Quote

  2. #2 Anonymous, Mar 27, 2011 at 10:16 AM
    Anonymous

    Anonymous Guest

    Not going to happen, but I did have a prominent PAH physician wonder to me would bosentan have been approved if it came to market after ambrisentan. How the times change.
     
    Quote
  3. #3 Anonymous, Mar 28, 2011 at 5:11 PM
    Anonymous

    Anonymous Guest

    Of course the answer to that is "NO" - you have 0 advantage over Letairis.
     
    Quote
Reply to Thread